Valuation: Ind-Swift Laboratories Limited

Market Cap 35.27B 368M 321M 302M 275M 516M 517M 3.62B 1.4B 17.97B 1.38B 1.35B 57.97B P/E 2025
2.38x
P/E 2026 26.1x
Enterprise Value 31.05B 324M 283M 266M 242M 455M 455M 3.19B 1.23B 15.82B 1.22B 1.19B 51.05B EV / Sales 2025
0.12x
EV / Sales 2026 1.11x
Free-Float
36.27%
Yield 2025 *
-
Yield 2026 -
1 day+6.89%
1 week+7.08%
Current month+11.15%
1 month+23.92%
3 months+114.71%
6 months+202.58%
Current year+360.07%
1 week 320.2
Extreme 320.2
417
1 month 316.61
Extreme 316.61
417
Current year 87.25
Extreme 87.25
417
1 year 87.15
Extreme 87.15
417
3 years 68.72
Extreme 68.72
417
5 years 52.65
Extreme 52.65
417
10 years 15
Extreme 15
417
Manager TitleAgeSince
Chief Executive Officer 74 1995-01-03
Chief Executive Officer 44 2011-06-14
Director of Finance/CFO - 2018-09-28
Director TitleAgeSince
Director/Board Member 44 -
Chairman 74 -
Director/Board Member 35 2010-03-22
Date Insider Type Main position Quantity % Market Cap. Importance
9/12/24 Sell

Chief Financial Officer

30,000 0.0508%
Change 5-day change 1-year change 3-year change Capi.($)
+6.89%+7.08%+288.68%+373.50% 344M
-1.20%+0.62%+12.31%+63.06% 46.81B
-1.02%-1.29%+36.59%+104.00% 37.1B
+0.11%+5.76%+12.22%+95.15% 12.09B
-0.14%+2.45%-10.25%+16.71% 11.69B
0.00%-0.95%+19.27%+142.99% 9.03B
-0.85%+0.95%+27.42%+38.91% 7.45B
+0.47%+3.78%+21.98%+206.60% 7.22B
-0.06%+2.20%+39.67%-16.79% 7.13B
+3.26%+3.77%-40.07%+13.57% 5.19B
Average +0.74%+1.63%+40.78%+103.77% 14.4B
Weighted average by Cap. -0.55%+1.02%+18.55%+78.49%

Financials

2025 2026
Net sales 5.62B 58.63M 51.12M 48.15M 43.85M 82.21M 82.31M 577M 222M 2.86B 220M 215M 9.23B 6.49B 67.76M 59.08M 55.64M 50.67M 95.01M 95.12M 666M 257M 3.31B 255M 249M 10.67B
Net income 2.5B 26.15M 22.8M 21.47M 19.55M 36.66M 36.71M 257M 99.1M 1.28B 98.21M 96.03M 4.12B 431M 4.5M 3.92M 3.7M 3.37M 6.31M 6.32M 44.27M 17.06M 220M 16.91M 16.53M 709M
Net Debt -4.27B -44.52M -38.82M -36.56M -33.3M -62.43M -62.51M -438M -169M -2.17B -167M -164M -7.01B -4.21B -43.97M -38.34M -36.11M -32.88M -61.65M -61.73M -432M -167M -2.15B -165M -162M -6.92B
Logo Ind-Swift Laboratories Limited
Ind-Swift Laboratories Limited is an India-based company, which is engaged in the business of manufacturing active pharmaceutical ingredients (APIs), intermediates and formulations. The Company operates in the Pharmaceutical Business segment. It also focuses on manufacturing formulations. The Company’s products include APIs and Impurities. Its APIs therapeutic category includes Macrolide Antibiotic, Cardiovascular, Antihistaminic, Antidiabetic, Antipsyhotic, Bone Resorption Inhibitor, and Aromatase Inhibitor. Its products include Clarithromycin, Clarithromycin Coated Granules, Clarithromycin Citrate, Atorvastatin Calcium Crystalline, Atorvastatin Calcium Amorphous, Clopidogrel HCl, Ezetimibe, Ivabradine Oxalate, Ranolazine, Aripiprazole, Risedronate Sodium, Ropinirole HCl, Cinacalcet HCl, Letrozole, and Anastrozole. Its products under development include Sitagliptin Phosphate, Mirabegron, Bempedoic Acid, Lasmiditan, and Eltrombopag Olamine.
Employees
1,388
Date Price Change Volume
26-09-22 405.55 +6.89% 2,018,474
26-09-21 ₹379.40 +1.65% 762,788
26-09-18 ₹373.25 -1.32% 399,757
26-09-17 ₹378.25 +3.94% 545,009
26-09-16 ₹363.90 -3.92% 1,637,019
  1. Stock Market
  2. Stocks
  3. INDSWFTLAB Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!